BMP-7 treatment increases M2 macrophage differentiation and reduces inflammation and plaque formation in Apo E-/-Mice

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Singla, Dinender K ^a   Singla, Reetu ^a   Wang, Jing ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOGENIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; APOLIPOPROTEIN E; ARG1 PROTEIN, MOUSE; ARGINASE; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CCL2 PROTEIN, MOUSE; IL10 PROTEIN, MOUSE; IL1RN PROTEIN, MOUSE; PROTECTIVE AGENT; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CAROTID ARTERY; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KNOCKOUT MOUSE; LIGATION; METABOLISM; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION; SURGERY;

ANIMALS; APOLIPOPROTEINS E; ARGINASE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CAROTID ARTERIES; CELL DIFFERENTIATION; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; LIGATION; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MONOCYTES; PLAQUE, ATHEROSCLEROTIC; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84959017327     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147897     Document Type: Article

References (35)

1. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014; 114: 1852-1866. doi: 10.1161/CIRCRESAHA.114.302721 PMID: 24902970
2. Hartman J, Frishman WH. Inflammation and atherosclerosis: A review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014; 22: 147-151. PMID: 24618929
3. Grenon SM, Aguado-Zuniga J, Hatton JP, Owens CD, Conte MS, Hughes-Fulford M. Effects of fatty acids on endothelial cells: Inflammation and monocyte adhesion. J Surg Res. 2012; 177: E35-43. doi: 10.1016/j.jss.2012.04.010 PMID: 22572621
4. den Hartigh LJ, Altman R, Norman JE, Rutledge JC. Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFkappaB. Am J Physiol Heart Circ Physiol. 2014; 306: H109-120. doi: 10.1152/ajpheart.00137.2013 PMID: 24163071
5. Italiani P, Boraschi D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Front Immunol. 2014; 5: 514. doi: 10.3389/fimmu.2014.00514 PMID: 25368618
6. Laskin DL. Macrophages and inflammatory mediators in chemical toxicity: A battle of forces. Chem Res Toxicol. 2009; 22: 1376-1385. doi: 10.1021/tx900086v PMID: 19645497
7. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004; 25: 677-686. PMID: 15530839
8. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011; 145: 341-355. doi: 10.1016/j.cell.2011.04.005 PMID: 21529710
9. Rocher C, Singla R, Singal PK, Parthasarathy S, Singla DK. Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages. Can J Physiol Pharmacol. 2012; 90: 947-951. doi: 10.1139/y2012-102 PMID: 22720873
10. Boon MR, van der Horst G, van der Pluijm G, Tamsma JT, Smit JW, Rensen PC. Bone morphogenetic protein 7: A broad-spectrum growth factor with multiple target therapeutic potency. Cytokine Growth Factor Rev. 2011; 22: 221-229. doi: 10.1016/j.cytogfr.2011.08.001 PMID: 21924665
11. Merino H, Parthasarathy S, Singla DK. Partial ligation-induced carotid artery occlusion induces leukocyte recruitment and lipid accumulation-A shear stress model of atherosclerosis. Mol Cell Biochem. 2013; 372: 267-273. doi: 10.1007/s11010-012-1468-7 PMID: 23054191
12. Papadopoulou C, Corrigall V, Taylor PR, Poston RN. The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques. Cytokine. 2008; 43: 181-186. PMID: 18579408
13. Torroella-Kouri M, Rodriguez D, Caso R. Alterations in macrophages and monocytes from tumor-bearing mice: Evidence of local and systemic immune impairment. Immunol Res. 2013; 57: 86-98. doi: 10. 1007/s12026-013-8438-3 PMID: 24203436
14. Guedj K, Khallou-Laschet J, Clement M, Morvan M, Gaston AT, Fornasa G, et al. M1 macrophages act as LTbetaR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Cardiovasc Res. 2014; 101: 434-443. doi: 10.1093/cvr/cvt263 PMID: 24272771
15. Mahmood DF, Abderrazak A, Couchie D, Lunov O, Diderot V, Syrovets T, et al. Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis. J Cell Physiol. 2013; 228: 1577-1583. doi: 10.1002/jcp.24319 PMID: 23335265
16. Fadini GP, Cappellari R, Mazzucato M, Agostini C, Vigili de Kreutzenberg S, Avogaro A. Monocytemacrophage polarization balance in pre-diabetic individuals. Acta Diabetol. 2013; 50: 977-982. doi: 10. 1007/s00592-013-0517-3 PMID: 24085683
17. Brown BN, Ratner BD, Goodman SB, Amar S, Badylak SF. Macrophage polarization: An opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials. 2012; 33: 3792-3802. doi: 10.1016/j.biomaterials.2012.02.034 PMID: 22386919
18. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8: 958-969. doi: 10.1038/nri2448 PMID: 19029990
19. Meyrelles SS, Peotta VA, Pereira TM, Vasquez EC. Endothelial dysfunction in the apolipoprotein Edeficient mouse: Insights into the influence of diet, gender and aging. Lipids Health Dis. 2011; 10: 211. doi: 10.1186/1476-511X-10-211 PMID: 22082357
20. Lessner SM, Prado HL, Waller EK, Galis ZS. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am J Pathol. 2002; 160: 2145-2155. PMID: 12057918
21. Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Apolipoprotein E knock-out and knock-in mice: Atherosclerosis, metabolic syndrome, and beyond. J Lipid Res. 2009; 50 Suppl: S178-182. doi: 10.1194/jlr.R800070-JLR200 PMID: 19060252
22. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb. 1994; 14: 141-147. PMID: 8274470
23. Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 2006; 113: 2744-2753. PMID: 16754802
24. Korshunov VA, Berk BC. Flow-induced vascular remodeling in the mouse: A model for carotid intimamedia thickening. Arterioscler Thromb Vasc Biol. 2003; 23: 2185-2191. PMID: 14576075
25. Ni CW, Qiu H, Rezvan A, Kwon K, Nam D, Son DJ, et al. Discovery of novel mechanosensitive genes in vivo using mouse carotid artery endothelium exposed to disturbed flow. Blood. 2010; 116: E66-73. doi: 10.1182/blood-2010-04-278192 PMID: 20551377
26. Dorai H, Vukicevic S, Sampath TK. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol. 2000; 184: 37-45. PMID: 10825232
27. Saika S, Ikeda K, Yamanaka O, Flanders KC, Nakajima Y, Miyamoto T, et al. Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice. Lab Invest. 2005; 85: 474-486. PMID: 15696184
28. Zhang XL, Selbi W, de la Motte C, Hascall V, Phillips AO. Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells. J Am Soc Nephrol. 2005; 16: 79-89. PMID: 15574511
29. Rocher C, Singla DK. SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages. PLoS One. 2013; 8: E84009. doi: 10.1371/journal.pone.0084009 PMID: 24376781
30. Lee MJ, Yang CW, Jin DC, Chang YS, Bang BK, Kim YS. Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells: Role for JNK/AP-1 pathway. J Immunol. 2003; 170: 2557-2563. PMID: 12594282
31. Maric I, Poljak L, Zoricic S, Bobinac D, Bosukonda D, Sampath KT, et al. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J Cell Physiol. 2003; 196: 258-264. PMID: 12811818
32. Urbina P, Singla DK. BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2014; 307: H762-772. doi: 10. 1152/ajpheart.00367.2014 PMID: 24993041
33. Takahashi T, Muneta T, Tsuji K, Sekiya I. BMP-7 inhibits cartilage degeneration through suppression of inflammation in rat zymosan-induced arthritis. Cell Tissue Res. 2011; 344: 321-332. doi: 10.1007/s00441-011-1154-1 PMID: 21484415
34. Shimizu T, Kayamori T, Murayama C, Miyamoto A. Bone morphogenetic protein (BMP)-4 and BMP-7 suppress granulosa cell apoptosis via different pathways: BMP-4 via PI3K/PDK-1/Akt and BMP-7 via PI3K/PDK-1/PKC. Biochem Biophys Res Commun. 2012; 417: 869-873. PMID: 22209843
35. Perron JC, Dodd J. ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis. PLoS One. 2009; 4: E8198. doi: 10.1371/journal.pone. 0008198 PMID: 20011660